Serum amyloid A as a biomarker: diagnostic relevance and clinical association with acute ischemic stroke
Date Issued
2025-10-16
Author(s)
Ivanovska, Slavjana
Kerala, Coskun
Kostovska, Irena
Abstract
Serum amyloid A (SAA) is an acute-phase protein that circulates at low levels bound to high-density lipoproteins (HDL). During inflammation, its concentration rises sharply, altering HDL composition, lipid transport, and cholesterol metabolism. These changes contribute to vascular pathology, particularly atherosclerosis. Owing to its multifunctional role, SAA has gained attention as a potential biomarker in cardiovascular and cerebrovascular diseases, although its role in acute ischemic stroke (AIS) remains insufficiently clarified.
File(s)![Thumbnail Image]()
Loading...
Name
ICOF MAG FINAL.pdf
Size
77.67 MB
Format
Adobe PDF
Checksum
(MD5):6d8e86d75b55b5c95b18d9b95401016d